WESTON, Mass.--(BUSINESS WIRE)--Biogen Idec Inc. (NASDAQ: BIIB) announced today that it will present at the 30th Annual J.P. Morgan Healthcare Conference. The webcast will be live on Monday, January 9, 2012 at 2:30 p.m. PT, 5:30 p.m. ET. To access the webcast, please visit Biogen Idec’s Investor Relations section (www.investor.biogenidec.com). An archived version will be available for 14 days following the presentation.
About Biogen Idec
Through cutting-edge science and medicine, Biogen Idec discovers, develops and delivers to patients worldwide innovative therapies for the treatment of neurodegenerative diseases, hemophilia and autoimmune disorders. Founded in 1978, Biogen Idec is the world’s oldest independent biotechnology company. Patients worldwide benefit from its leading multiple sclerosis therapies, and the company generates nearly $5 billion in annual revenues. For product labeling, press releases and additional information about the company, please visit www.biogenidec.com.
Contact:
Biogen Idec
Kia Khaleghpour, 781-464-2442
Investor Relations
